Home›Stock Screener›Gujarat Themis Biosyn›Financial Statements

Gujarat Themis Biosyn Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Gujarat Themis Biosyn (GUJTHEM) reported revenue ₹166 Cr, net profit ₹51 Cr and EPS ₹4.28, with a net profit margin of 30.7% and ROE of 17.7%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse GUJTHEM FII DII holdings to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 30.72% 2026 data
EBITDA Margin 45.78% 2026 data
Operating Margin 46.00% 2026 data
Return on Assets 10.14% 2026 data
Return on Equity 17.71% 2026 data

Balance Sheet Ratios

Current Ratio 0.65 2026 data
Equity Ratio 57.26% 2026 data
Asset Turnover 0.33 2026 data

GUJTHEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

GUJTHEM YoY (March 2025 vs March 2026) — revenue +8.5%, net profit +4.1%, EBITDA +7.0%, expenses +11.1%. For live price, earnings ratios and company overview, see Gujarat Themis Biosyn share price today.

Revenue Growth
+8.5%
Year-over-Year
Net Profit Growth
+4.1%
Year-over-Year
EBITDA Growth
+7.0%
Year-over-Year
Expense Growth
+11.1%
Year-over-Year
Assets Growth
+67.1%
Year-over-Year
Equity Growth
+16.1%
Year-over-Year
Operating Cash Flow Growth
+42.2%
Year-over-Year
Investing Cash Flow Growth
-103.6%
Year-over-Year
Financing Cash Flow Growth
+388.9%
Year-over-Year

GUJTHEM Income Statement — Revenue, EBITDA & Net Profit

Gujarat Themis Biosyn revenue ₹166 Cr, EBITDA ₹76 Cr, net profit ₹51 Cr, EPS ₹4.28 (2026) — net profit margin 30.7%. Also explore GUJTHEM share price charts to track price trends across different timeframes.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 166 153 174 155 119 94 87 43 39 36 33 32
Expenses 90 81 91 75 57 50 53 34 33 30 27 25
EBITDA 76 71 83 80 62 44 34 10 6 6 6 6
Operating Profit Margin % 46.00% 46.00% 46.00% 50.00% 51.00% 45.00% 37.00% 18.00% 16.00% 17.00% 19.00% 20.00%
Depreciation 13 5 4 3 2 2 1 1 1 1 1 1
Interest 3 0 0 0 1 1 1 0 0 0 0 0
Profit Before Tax 62 66 79 78 59 41 31 8 5 5 5 5
Tax 11 17 20 20 15 11 8 2 1 1 0 0
Net Profit 51 49 59 58 44 30 24 6 4 4 5 5
Earnings Per Share (₹) 4.28 4.48 40.72 39.90 30.03 20.77 16.30 4.41 2.66 3.01 3.19 3.16

GUJTHEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

GUJTHEM total assets ₹503 Cr, total equity ₹288 Cr, total liabilities ₹ Cr (2026) — ROE 17.7%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 503 301 221 166 123 88 64 33 21 21 15 15
Current Assets 89 52 48 62 78 63 29 8 8 8 3 4
Fixed Assets 410 41 38 33 19 19 17 15 11 11 9 10
Capital Work in Progress 121 184 91 21 13 2 0 1 0 0 0 0
Investments 15 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 76 92 113 90 67 47 17 10 11 5 5
LIABILITIES
Total Liabilities
Current Liabilities 137 32 4 2 2 3 5 1 1 1 2 6
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 288 248 201 149 103 70 42 19 12 8 4 -1
Share Capital 11 11 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 277 238 194 142 96 63 35 11 5 1 -3 -8

GUJTHEM Cash Flow Statement — Operating, Investing & Financing

Gujarat Themis Biosyn operating cash flow ₹91 Cr, investing ₹-112 Cr, financing ₹26 Cr, net cash flow ₹5 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 91 64 40 40 11 1 1 6 3 4 3
Investing Activities -112 -55 -20 -30 -2 -3 -6 -1 -3 -1 0
Financing Activities 26 -9 -13 -14 -5 2 5 -4 0 -3 -3
Net Cash Flow 5 0 6 -4 3 0 0 1 0 0 -1